A new study finds that multiple sclerosis patients who have not participated in a clinical trial say disclosure is important enough to influence their participation in industry-sponsored clinical trials.
Via Pharma Guy
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
PATIENT EMPOWERMENT & E-PATIENT
Patients as the healthcare system "missing link" #digitalhealth #hcsmeu #hcsm #epatient Curated by Lionel Reichardt / le Pharmageek |
Interestingly, financial disclosure is NOT part of the "informed consent" documents shown to patients before they join a clinical trial.
I have a question: Do pharmaceutical companies pay physicians to recruit patients into trials that the physicians are otherwise not involved in?
It seems to me that transparency should be one of the "pillars" of patient centricity, which is a subject I will discuss in a March 20, 2105, podcast interview of Anne C. Beal, MD, MPH, Chief Patient Officer, Sanofi, and Melva T. Covington, MPH, MBA., PhD, Project Leader, Research and Develooment, Sanofi. They talk about their roles in bringing the patient perspective into Sanofi's work to advance Sanofi's ability to deliver health care solutions that matter most to patients and those who care for them. Listen here.